Mehran Makvandi Selected Research

DOTA(0)-Tyr(3)-Thr(8)- 111In-octreotate

12/2016

Improved safety and efficacy of 213Bi-DOTATATE-targeted alpha therapy of somatostatin receptor-expressing neuroendocrine tumors in mice pre-treated with L-lysine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mehran Makvandi Research Topics

Disease

20	Neoplasms (Cancer) 01/2022 - 11/2015
5	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 02/2017
4	Neuroblastoma 02/2021 - 01/2017
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 11/2017
3	Breast Neoplasms (Breast Cancer) 01/2019 - 01/2016
2	Inflammation (Inflammations) 01/2022 - 01/2018
2	Neuroinflammatory Diseases 01/2019 - 01/2019
1	Edema (Dropsy) 01/2022
1	Lung Injury 01/2022
1	Pulmonary Edema 01/2022
1	Glioblastoma (Glioblastoma Multiforme) 02/2021
1	Neoplasm Micrometastasis 01/2020
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 01/2018
1	Prostatic Neoplasms (Prostate Cancer) 01/2018
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 12/2016
1	Triple Negative Breast Neoplasms 11/2015
1	Hypertrophy 12/2013
1	Hypertension (High Blood Pressure) 12/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2013

Drug/Important Bio-Agent (IBA)

10	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 01/2016
6	Pharmaceutical PreparationsIBA 01/2022 - 11/2015
6	LigandsIBA 01/2019 - 01/2016
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2016
4	sigma-2 receptorIBA 01/2019 - 11/2015
3	EnzymesIBA 01/2020 - 12/2016
3	Radioisotopes (Radionuclides)IBA 01/2019 - 12/2016
2	Poly Adenosine Diphosphate RiboseIBA 01/2022 - 01/2020
2	RadiopharmaceuticalsIBA 12/2020 - 01/2020
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2020 - 01/2018
2	ChromatinIBA 01/2020 - 01/2019
2	AZD2461IBA 01/2019 - 08/2018
2	olaparibIBA 08/2018 - 01/2017
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	Imatinib Mesylate (Gleevec)FDA Link 01/2022
1	Investigational DrugsIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 02/2021
1	Death Domain ReceptorsIBA 02/2021
1	B7-H1 AntigenIBA 02/2021
1	Adenosine Diphosphate Ribose (ADP-Ribose)IBA 12/2020
1	Adenosine Diphosphate (ADP)IBA 12/2020
1	Estrogens (Estrogen)FDA Link 01/2019
1	alovudineIBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Fulvestrant (Faslodex)FDA Link 01/2019
1	Estrogen ReceptorsIBA 01/2019
1	Cyclin-Dependent Kinase 4IBA 01/2019
1	palbociclibIBA 01/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 08/2018
1	Radium-223IBA 01/2018
1	Biological ProductsIBA 11/2017
1	3-Iodobenzylguanidine (Iobenguane)IBA 01/2017
1	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 01/2017
1	IodineIBA 01/2017
1	Dexmedetomidine FDA Link 01/2017
1	SV119IBA 01/2017
1	DOTA(0)-Tyr(3)-Thr(8)- 111In-octreotateIBA 12/2016
1	Lysine (L-Lysine)FDA Link 12/2016
1	Peptides (Polypeptides)IBA 12/2016
1	Somatostatin Receptors (Somatostatin Receptor)IBA 12/2016
1	Peptide Receptors (Peptide Receptor)IBA 12/2016
1	benzamideIBA 11/2016
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 12/2013
1	Nicotine FDA Link 12/2013

Therapy/Procedure

12	Therapeutics 02/2021 - 12/2013
2	Radiotherapy 02/2017 - 01/2017
1	Artificial Respiration (Mechanical Ventilation) 01/2022
1	Immunotherapy 02/2021
1	Precision Medicine 12/2020
1	Tobacco Use Cessation Devices 12/2013